These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 37392735)

  • 1. CXCR3 expression in regulatory T cells drives interactions with type I dendritic cells in tumors to restrict CD8
    Moreno Ayala MA; Campbell TF; Zhang C; Dahan N; Bockman A; Prakash V; Feng L; Sher T; DuPage M
    Immunity; 2023 Jul; 56(7):1613-1630.e5. PubMed ID: 37392735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exercise Training Improves Tumor Control by Increasing CD8
    Gomes-Santos IL; Amoozgar Z; Kumar AS; Ho WW; Roh K; Talele NP; Curtis H; Kawaguchi K; Jain RK; Fukumura D
    Cancer Immunol Res; 2021 Jul; 9(7):765-778. PubMed ID: 33839688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratumoral Activity of the CXCR3 Chemokine System Is Required for the Efficacy of Anti-PD-1 Therapy.
    Chow MT; Ozga AJ; Servis RL; Frederick DT; Lo JA; Fisher DE; Freeman GJ; Boland GM; Luster AD
    Immunity; 2019 Jun; 50(6):1498-1512.e5. PubMed ID: 31097342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-γ, CXCL9 and CXCL10.
    Bergamaschi C; Pandit H; Nagy BA; Stellas D; Jensen SM; Bear J; Cam M; Valentin A; Fox BA; Felber BK; Pavlakis GN
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory T cells control endothelial chemokine production and migration of T cells into intestinal tumors of APC
    Akeus P; Szeponik L; Ahlmanner F; Sundström P; Alsén S; Gustavsson B; Sparwasser T; Raghavan S; Quiding-Järbrink M
    Cancer Immunol Immunother; 2018 Jul; 67(7):1067-1077. PubMed ID: 29671006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NOD2 regulates CXCR3-dependent CD8+ T cell accumulation in intestinal tissues with acute injury.
    Wu X; Lahiri A; Haines GK; Flavell RA; Abraham C
    J Immunol; 2014 Apr; 192(7):3409-18. PubMed ID: 24591373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treg-cell depletion promotes chemokine production and accumulation of CXCR3(+) conventional T cells in intestinal tumors.
    Akeus P; Langenes V; Kristensen J; von Mentzer A; Sparwasser T; Raghavan S; Quiding-Järbrink M
    Eur J Immunol; 2015 Jun; 45(6):1654-66. PubMed ID: 25754875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DPP inhibition alters the CXCR3 axis and enhances NK and CD8+ T cell infiltration to improve anti-PD1 efficacy in murine models of pancreatic ductal adenocarcinoma.
    Fitzgerald AA; Wang S; Agarwal V; Marcisak EF; Zuo A; Jablonski SA; Loth M; Fertig EJ; MacDougall J; Zhukovsky E; Trivedi S; Bhatia D; O'Neill V; Weiner LM
    J Immunother Cancer; 2021 Nov; 9(11):. PubMed ID: 34737215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting resistance to radiation-immunotherapy in cold HNSCCs by modulating the Treg-dendritic cell axis.
    Knitz MW; Bickett TE; Darragh LB; Oweida AJ; Bhatia S; Van Court B; Bhuvane S; Piper M; Gadwa J; Mueller AC; Nguyen D; Nangia V; Osborne DG; Bai X; Ferrara SE; Boss MK; Goodspeed A; Burchill MA; Tamburini BAJ; Chan ED; Pickering CR; Clambey ET; Karam SD
    J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33883256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the Chemokine Receptor CXCR3 Correlates with Dendritic Cell Recruitment and Prognosis in Gastric Cancer.
    Chen F; Yin S; Niu L; Luo J; Wang B; Xu Z; Yang G
    Genet Test Mol Biomarkers; 2018 Jan; 22(1):35-42. PubMed ID: 29266971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue-specific abundance of interferon-gamma drives regulatory T cells to restrain DC1-mediated priming of cytotoxic T cells against lung cancer.
    Zagorulya M; Yim L; Morgan DM; Edwards A; Torres-Mejia E; Momin N; McCreery CV; Zamora IL; Horton BL; Fox JG; Wittrup KD; Love JC; Spranger S
    Immunity; 2023 Feb; 56(2):386-405.e10. PubMed ID: 36736322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD27 expression on Treg cells limits immune responses against tumors.
    Muth S; Klaric A; Radsak M; Schild H; Probst HC
    J Mol Med (Berl); 2022 Mar; 100(3):439-449. PubMed ID: 34423375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-X-C Motif Chemokine Ligand 9 and Its CXCR3 Receptor Are the Salt and Pepper for T Cells Trafficking in a Mouse Model of Gaucher Disease.
    Magnusen AF; Rani R; McKay MA; Hatton SL; Nyamajenjere TC; Magnusen DNA; Köhl J; Grabowski GA; Pandey MK
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoattractant Receptors BLT1 and CXCR3 Regulate Antitumor Immunity by Facilitating CD8+ T Cell Migration into Tumors.
    Chheda ZS; Sharma RK; Jala VR; Luster AD; Haribabu B
    J Immunol; 2016 Sep; 197(5):2016-26. PubMed ID: 27465528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors.
    Dangaj D; Bruand M; Grimm AJ; Ronet C; Barras D; Duttagupta PA; Lanitis E; Duraiswamy J; Tanyi JL; Benencia F; Conejo-Garcia J; Ramay HR; Montone KT; Powell DJ; Gimotty PA; Facciabene A; Jackson DG; Weber JS; Rodig SJ; Hodi SF; Kandalaft LE; Irving M; Zhang L; Foukas P; Rusakiewicz S; Delorenzi M; Coukos G
    Cancer Cell; 2019 Jun; 35(6):885-900.e10. PubMed ID: 31185212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiotherapy enhances CXCR3
    Wang CL; Ho AS; Chang CC; Sie ZL; Peng CL; Chang J; Cheng CC
    Cancer Immunol Immunother; 2023 Jun; 72(6):1865-1880. PubMed ID: 36688994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt-β-Catenin Signaling in Human Dendritic Cells Mediates Regulatory T-Cell Responses to Fungi via the PD-L1 Pathway.
    Karnam A; Bonam SR; Rambabu N; Wong SSW; Aimanianda V; Bayry J
    mBio; 2021 Dec; 12(6):e0282421. PubMed ID: 34781737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD8
    Farhood B; Najafi M; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8509-8521. PubMed ID: 30520029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCR3+ T regulatory cells selectively accumulate in human ovarian carcinomas to limit type I immunity.
    Redjimi N; Raffin C; Raimbaud I; Pignon P; Matsuzaki J; Odunsi K; Valmori D; Ayyoub M
    Cancer Res; 2012 Sep; 72(17):4351-60. PubMed ID: 22798340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade.
    House IG; Savas P; Lai J; Chen AXY; Oliver AJ; Teo ZL; Todd KL; Henderson MA; Giuffrida L; Petley EV; Sek K; Mardiana S; Gide TN; Quek C; Scolyer RA; Long GV; Wilmott JS; Loi S; Darcy PK; Beavis PA
    Clin Cancer Res; 2020 Jan; 26(2):487-504. PubMed ID: 31636098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.